The objective of this study was to determine the survival of patients with metastatic breast cancer in resource-limited settings. Patients and Methods: This was a cross-sectional descriptive study that took place in the Cancer Department of the General Hospital of Loandjili in Pointe Noire during ...
American women with metastatic breast cancer (MBC), the only form of the disease that is deadly, are now living longer than they did in the early 1990s, according to new research. The investigators also provide, for the first time, an estimate of the number of women living with MBC in ...
As such, the estimates for survival from this analysis would likely be higher than we would expect in the average population of patients with metastatic breast cancer presenting in the community today. Being able to provide this information as well as worst-case, median, and best-case scenarios...
We often hear metastatic breast cancer being described as more of a chronic condition today than it used to be. Dr. Wojciechowski says, “I don’t really buy that whole narrative, although I know we see legitimate success. The average survival is still 3 years. There is a small percentage...
a, Density plots showing the distribution of the average expression (log2 counts per million) of genes encoding for receptors of circadian-regulated hormones, growth factors or molecules in CTCs from NSG-CDX-BR16 mice, NSG-LM2 mice and patients with breast cancer. Genes for the glucocorticoid ...
Background In a Dutch multicentre study, elderly (65 + year) metastatic breast cancer patients, eligible for first-line chemotherapy, were randomised... E M.,Hamaker,and,... - 《Breast》 被引量: 12发表: 2013年 Immunotherapy in progressive metastatic cancer. A fifteen-year survival follow-up...
This was originally written as an extension so the bookThe Breast Cancer Journey: Stories of Hope with Action Items for Survival,a site designed to help those affected by breast cancer through your journey. Whether you have been recently diagnosed, have been a survivor for many years, or have...
CancerTevaarwerk AJ, Gray RJ, Schneider BP, Smith ML, Wagner LI, Fetting JH, Davidson N, Goldstein LJ, Miller KD and Sparano JA. Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years. Cancer 2013; 119:...
Patients with metastatic breast cancer have traditionally been considered incurable with conventional treatment. However, 5–10% of those patients survive more than 5years, and 2–5% survive more than 10years. Recent studies suggest that the survival of patients with metastatic breast cancer has been...
The risk for death was more than 200% greater for patients in the latter group than in the former group. Dr Wolfgang Janni The results "suggest the potential for clinical utility" of CTC monitoring as an early response marker in metastatic breast cancer, said lead author Wolfgang Janni, MD,...